Literature DB >> 12507063

Gabapentin withdrawal presenting as status epilepticus.

Fermin Barrueto1, Jonah Green, Mary Ann Howland, Robert S Hoffman, Lewis S Nelson.   

Abstract

A 34-year-old male with lumbar disc disease and surgery was placed on gabapentin daily for chronic back pain. He remained on a steady dose of 8000 mg/day for 9 months, almost doubled what is considered therapeutic. He ran out of medication, was unable to refill his prescription for 2 days and presented to the emergency department in status epilepticus. There was no previous history of seizure disorder and he was on no other medications. A medical evaluation for an alternative etiology of his seizures was negative. Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12507063     DOI: 10.1081/clt-120016965

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  10 in total

1.  Gabapentin misuse.

Authors:  Robin Lennox; Dee Mangin
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

Review 2.  Management of seizures in critically ill patients.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

3.  Complex encephalopathy arising from the combination of opioids and gabapentin.

Authors:  Harpreet Singh; Richa Handa; Vivek Kak; Alicja Wasilewski
Journal:  BMJ Case Rep       Date:  2019-04-20

4.  Gabapentin for smoking cessation.

Authors:  Amit Sood; Jon O Ebbert; Kirk D Wyatt; Ivana T Croghan; Darrell R Schroeder; Richa Sood; J Taylor Hays
Journal:  Nicotine Tob Res       Date:  2010-01-15       Impact factor: 4.244

Review 5.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

6.  Gabapentin Prevents Progressive Increases in Excitatory Connectivity and Epileptogenesis Following Neocortical Trauma.

Authors:  D K Takahashi; Sha Jin; D A Prince
Journal:  Cereb Cortex       Date:  2018-08-01       Impact factor: 5.357

7.  Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.

Authors:  Michael D Stein; Shannon R Kenney; Bradley J Anderson; Micah T Conti; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2019-12-13

8.  Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.

Authors:  Alyssa M Peckham; Kathleen A Fairman; David A Sclar
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

9.  A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.

Authors:  Gowhar Ali; Fazal Subhan; Muzaffar Abbas; Jehan Zeb; Muhammad Shahid; Robert D E Sewell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-03       Impact factor: 3.000

Review 10.  Gabapentin in acute postoperative pain management.

Authors:  Connie Y Chang; Chaitanya K Challa; Janki Shah; Jean Daniel Eloy
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.